Table.

Demographic and clinical characteristics of surveyed patients

		Surveyed patients (n=102)
Age (years)		52 (18–77)
Female		87 (85%)
Male		15 (15%)
Antiphospholipid antibody carrier		50 (49%)
Antiphospholipid syndrome		52 (51%)
	Primary antiphospholipid syndrome	38 (37%)
	Antiphospholipid syndrome associated to SLE	14 (14%)
	Thrombotic antiphospholipid syndrome	42 (41%)
	Obstetric antiphospholipid syndrome	10 (10%)
Antiphospholipid antibody profile
	Lupus anticoagulants	77 (76%)
	Anticardiolipin antibodies (IgG/IgM)	67 (66%)
	Anti-β2-glycoprotein 1 antibodies (IgG/IgM)	56 (55%)

Data are n (%) or median (range). SLE=systemic lupus erythematosus.